// App-Quantinova.ai

: Effect of tiotropium/olodaterol combination therapy on long-term heart rate and blood pressure in COPD patients

Researchers

Presenter

  • Stefan Andreas

Principal Investigators

  • Lorcan Mcgarvey

  • Ulrich Bothner

  • Matthias Trampisch

  • Alberto De La Hoz

  • Matjaz Flear

  • Peter Alter

  • Roland Buhl

Medical Centers

  • University Medical Center Göttingen and LungClinic Immenhausen, Göttingen, Germany

  • Queen's University Belfast, Belfast, United Kingdom

  • Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany,

  • Klinika Golnik, Golnik, Slovenia

  • Department of Medicine, Pulmonary and Critical Care Medicine, Philipps University of Marburg, Marburg, Germany,

  • Pulmonary Department, Johannes Gutenberg University Mainz, Mainz, Germany,

Locations

  • Germany

  • United Kingdom

  • Slovakia

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Tiotropium/olodaterol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT01431287

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved